HCV inhibiting bi-cyclic pyrimidines

Details for Australian Patent Application No. 2005288858 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Raboisson, Pierre Jean-Marie Bernard; Simmen, Kenneth Alan; Surleraux, Dominique Louis Nestor Ghislain; Lenz, Oliver; Lin, Tse-I

Agent Shelston IP

Pub. Number AU-B-2005288858

PCT Pub. Number WO2006/035061

Priority 04104815.8 30.09.04 EP; 05102810.8 08.04.05 EP

Filing date 29 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 21 April 2011

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5377 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/035061 Priority application(s): WO2006/035061

21 April 2011 Application Accepted

  Published as AU-B-2005288858

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005288864-HIV inhibiting 5-heterocyclyl pyrimidines

2005288848-A bacterial ATP synthase binding domain